The results show that tolbutamide does not change the blood levels of glucose and free fatty acid in diabetic patients with no reservation of insulin secretion, and that the effect of tolbutamide to decrease blood levels of glucose and free fatty acid in nondiabetic subjects or mild diabetics is mainly due to its insulin-secreting effect. Dulin et al. (1956) indirectly showed that release of catecholamine is increased by the administration of sulfonylurea using adrenal demedullated rats in vivo. This increase in catecholamine may be due to the hypoglycemia caused by insulin stimulated by sulfonylurea. 
